Health Care and Biotech
Alcidion’s IT Targets Hospital Efficiency
Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.
Dec 19 2016
Estia Health Beset By Uncertainty
Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.
Dec 13 2016
Rebound For Sirtex
Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.
Dec 13 2016
Sirtex Reaction Overdone
Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.
Dec 12 2016
Previous Stories
A Double Blessed Buy For Alchemia
Nov 30 2012
RBS Morgans sees a favourable set-up for biotech Alchemia.
Australian Stocks: What Happened Today?
Nov 29 2012
A wrap of the day’s activity on the Australian stock market.
CSL Blows Them Away
Nov 28 2012
CSL surprised the market with an increase in full year earnings guidance yesterday and brokers have responded by lifting targets and ratings.
Australian Stocks: What Happened Today?
Nov 27 2012
A wrap of the day’s activity on the Australian stock market.
Pathology Regulation Fear Overdone
Nov 22 2012
Agreement on redemption of pathology over-spending delivers minimal impact on Sonic Healthcare and Primary Health Care.
Weekly Broker Wrap: Obamacare And The Oz Health Sector
Nov 12 2012
Pondering the Obamacare impact on the Oz health sector, plus the latest on bank stress testing, an update on retailers and a look at Santos and Origin.
ResMed Arises
Oct 29 2012
ResMed delivered a solid quarterly seeing brokers lift earnings forecasts, but ratings remain split between Buy and Hold given concerns with respect to competitive bidding.
Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes
Oct 29 2012
Weekly update on recommendation, target price, and earnings forecast changes.
Weekly Broker Wrap: A Little Bit More Optimism
Oct 22 2012
Survey shows fund managers a little more upbeat, while a new issue arises for Banks and Healthcare to remain stronger for a little longer.
Treasure Chest: CSL Re-Rating Overdue
Oct 17 2012
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. UBS lits its CSL target price by 12% and upgrades to Buy post a US field trip.
Analyse The Market From A Different Angle
Latest News
| 1 |
The Market In Numbers – 25 Jan 20259:09 AM - Australia |
| 2 |
ASX Winners And Losers Of Today – 24-01-25Jan 24 2025 - Daily Market Reports |
| 3 |
Next Week At A Glance – 27-31 Jan 2025Jan 24 2025 - Weekly Reports |
| 4 |
Chrysos Corp’s Road Paved With GoldJan 24 2025 - Small Caps |
| 5 |
Weekly Top Ten News Stories – 24 January 2025Jan 24 2025 - Weekly Reports |